CFM Indosuez Wealth (XPAR:MLCFM) Research & Development: €0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:MLCFM CFM Indosuez Wealth SA XPAR:MLCFM
19 GF Score
Price €1,330.00
GF Value €1,157.58
! 7 Warning Signs
View Full Analysis

What is CFM Indosuez Wealth Research & Development?

CFM Indosuez Wealth XPAR:MLCFM 19 Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus rates XPAR:MLCFM with a GF Score™ of 19/100 and a GF Value™ of €1,157.58. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CFM Indosuez Wealth's Research & Development for the six months ended in Dec. 2025 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

CFM Indosuez Wealth  (XPAR:MLCFM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CFM Indosuez Wealth Research & Development Related Terms

CFM Indosuez Wealth Research & Development Historical Data

* Premium members only.

The historical data trend for CFM Indosuez Wealth's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CFM Indosuez Wealth Research & Development Chart

CFM Indosuez Wealth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CFM Indosuez Wealth Semi-Annual Data
Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XPAR:MLCFM
19GF Score
CFM Indosuez Wealth SA XPAR:MLCFM
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CFM Indosuez Wealth Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
CFM Indosuez Wealth (XPAR:MLCFM) has a Research & Development of €0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on CFM Indosuez Wealth and its competitors.
Is CFM Indosuez Wealth's Research & Development too high?
CFM Indosuez Wealth's current Research & Development is €0.0 Mil. Overall, CFM Indosuez Wealth has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does CFM Indosuez Wealth's Research & Development compare to competitors?
CFM Indosuez Wealth's Research & Development of €0.0 Mil can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Banks company?
A good Research & Development depends on the Banks industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CFM Indosuez Wealth and its competitors. CFM Indosuez Wealth's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CFM Indosuez Wealth stock overvalued right now?
CFM Indosuez Wealth (XPAR:MLCFM) has a current Research & Development of €0.0 Mil. The stock's GF Value™ is €1,157.58, compared to a current price of €1,330.00 — trading 14.9% above its estimated fair value. The current Research & Development is €0.0 Mil. CFM Indosuez Wealth's overall GF Score™ is 19/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CFM Indosuez Wealth (XPAR:MLCFM), the current Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CFM Indosuez Wealth (XPAR:MLCFM) Overvalued in 2026?

Based on GuruFocus' analysis, CFM Indosuez Wealth stock appears to be overvalued. The current stock price of €1,330.00 is trading 14.9% above its estimated GF Value™ of €1,157.58.

Key valuation signals for XPAR:MLCFM:

  • Research & Development: €0.0 Mil
  • GF Value™: €1,157.58 vs. price of €1,330.00 (14.9% above fair value)
  • GF Score™: 19/100 with 7 warning signs

No single metric tells the full story. See the XPAR:MLCFM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CFM Indosuez Wealth Business Description

Address 11, boulevard Albert 1er, Monaco, MCO, 98000
CFM Indosuez Wealth SA is in the business of wealth management. Its services include tailor-made wealth management recommendations, international investment solutions, precision banking services, credit solutions, special access to Credit Agricole group's expertise and wealth and beyond. The company's product lines are discretionary portfolio management, advisory, direct access, investment funds, structured products, forex and precious metals, private equity, real estate and insurance. Its operations are in Americas, Asia-Pacific, Europe, Middle East and Africa.
19GF Score

Get the complete analysis for XPAR:MLCFM

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1,330.00
Price
€1,157.58
GF Value